Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis

This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhongxiu, Li, Yajiao, Dian, Ke, Rao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505060/
https://www.ncbi.nlm.nih.gov/pubmed/28740551
http://dx.doi.org/10.7150/thno.19286
_version_ 1783249408803995648
author Chen, Zhongxiu
Li, Yajiao
Dian, Ke
Rao, Li
author_facet Chen, Zhongxiu
Li, Yajiao
Dian, Ke
Rao, Li
author_sort Chen, Zhongxiu
collection PubMed
description This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibrosis treatment.
format Online
Article
Text
id pubmed-5505060
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-55050602017-07-24 Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis Chen, Zhongxiu Li, Yajiao Dian, Ke Rao, Li Theranostics Commentary This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibrosis treatment. Ivyspring International Publisher 2017-06-01 /pmc/articles/PMC5505060/ /pubmed/28740551 http://dx.doi.org/10.7150/thno.19286 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Commentary
Chen, Zhongxiu
Li, Yajiao
Dian, Ke
Rao, Li
Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
title Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
title_full Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
title_fullStr Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
title_full_unstemmed Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
title_short Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
title_sort modulating micrornas as novel therapeutic targets in cardiac fibrosis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505060/
https://www.ncbi.nlm.nih.gov/pubmed/28740551
http://dx.doi.org/10.7150/thno.19286
work_keys_str_mv AT chenzhongxiu modulatingmicrornasasnoveltherapeutictargetsincardiacfibrosis
AT liyajiao modulatingmicrornasasnoveltherapeutictargetsincardiacfibrosis
AT dianke modulatingmicrornasasnoveltherapeutictargetsincardiacfibrosis
AT raoli modulatingmicrornasasnoveltherapeutictargetsincardiacfibrosis

Ejemplares similares